ML17054D281
| ML17054D281 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 03/01/2017 |
| From: | Alexander Adams NRC/NRR/DPR/PRLB |
| To: | Piefer G SHINE Medical Technologies |
| Lynch S, NRR/DPR/PRLB, 301-415-1524 | |
| References | |
| TAC MF9090 | |
| Download: ML17054D281 (4) | |
Text
March 1, 2017 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, INC. - REVIEW OF SAFEGUARDS INFORMATION PROTECTION PROGRAM (TAC NO. MF9090)
Dear Dr. Piefer:
By letter dated December 20, 2016 (Agencywide Documents Access and Management System
[ADAMS] Accession No. ML16364A091), SHINE Medical Technologies, Inc. (SHINE) submitted its Safeguards Information (SGI) Protection Program procedures for U.S. Nuclear Regulatory Commission (NRC) review.
By letter dated February 6, 2017 (ADAMS Accession No. ML17031A443), the NRC staff issued a letter requesting additional information to complete its review. This information was necessary to demonstrate SHINEs compliance with the regulations contained in Title 10 of the Code of Federal Regulations (10 CFR) Part 73, Physical Protection of Plants and Materials, and 10 CFR Part 50, Domestic Licensing of Production and Utilization Facilities. By letter dated February 7, 2017 (ADAMS Accession No. ML17040A138), SHINE responded to this request for information, including necessary revisions to its SGI Protection Program procedures.
Based upon its review of SHINEs SGI Protection Program procedures, as revised, the NRC staff has determined that SHINE has provided sufficient assurance that it will protect SGI that it produces, receives, or acquires from unauthorized disclosure in accordance with the requirements of 10 CFR 73.21, Protection of Safeguards Information: Performance Requirements, and 10 CFR 73.22, Protection of Safeguards Information: Specific Requirements.
The implementation of SHINEs SGI Protection Program procedures relates solely to safeguards matters and does not involve any significant construction impacts. Accordingly, this action meets the eligibility criteria for categorical exclusion set forth in 10 CFR 51.22, Criterion for categorical exclusion; identification of licensing and regulatory actions eligible for categorical exclusion or otherwise not requiring environmental review, specifically, it meets the categorical exclusion in 10 CFR 51.22(c)(12).
Pursuant to 10 CFR 51.22(b), no environmental impact statement or environmental assessment need be prepared in connection with the implementation of SHINEs SGI Protection Program procedures.
If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov..
Sincerely,
/RA Duane Hardesty Acting For/
Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608 cc: See next page
SHINE Medical Technologies, Inc.
Docket No. 50-608 cc:
Jeff Batelme Licensing Manager SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 Jeff Chamberlin National Nuclear Security Administration NA-231 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 TRTR Newsletter University of Florida Department of Nuclear Engineering Sciences 202 Nuclear Sciences Center Gainesville, FL 32611 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548 Gerald and Muriel Bumgarner 1735 S Osborne Ave Janesville, WI 53546
ML17054D281; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB*
NRR/DPR/LA*
NRR/DPR/PROB OGC NRR/DPR/PRLB NAME SLynch NParker EReed NSt.Amour AAdams (DHardesty for)
DATE 2/28/17 2/28/17 2/28/17 3/1/17 3/1/17